DX-8951f
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for DX-8951f, covering 2012-05-16 to 2013-07-10. Get the full timeline:
Most recent: Clinical Trial Update: DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]